Skip to content

ED50 of propofol versus cyclopropofol for induction of intubation in patients with sarcopenia, a prospective, randomized controlled clinical study

ED50 of propofol versus cyclopropofol for induction of intubation in patients with sarcopenia, a prospective, randomized controlled clinical study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097273
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-03-25
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Positive response to tracheal intubation

Interventions

Propofol group:The initial dose of propofol is 2mg/kg, administered over 30 seconds. If the previous patient exhibits a positive response, the dose is increased for the next patient. If the previous p
Ciprofol group:The initial dose of ciprofol is 0.4mg/kg, administered over 30 seconds. If the previous patient exhibits a positive response, the dose is increased for the next patient. If the previou

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Voluntarily participate and sign the informed consent form. 2.Scheduled to undergo urological surgery under general anesthesia with tracheal intubation, with an ASA physical status classification of I-III. 3.Age >=60 years. 4.Body mass index (BMI) between 18 and 28 kg/m². 5.Diagnosed with sarcopenia.

Exclusion criteria

Exclusion criteria: 1.Contraindications to general anesthesia. 2.Allergy to the study drugs (ciprofol, propofol, sufentanil, or rocuronium). 3.Severe cardiovascular or cerebrovascular diseases, respiratory diseases, hematological disorders, endocrine disorders, or hepatic/renal dysfunction. 4.Predictable difficult airway or high-risk factors for difficult laryngoscopy/intubation. 5.Positive Allen’s test or hemodynamic instability (systolic blood pressure 180 mmHg, diastolic blood pressure >110 mmHg, heart rate =110 beats/min, or peripheral oxygen saturation <90%). 6.Inability to communicate effectively.

Design outcomes

Primary

MeasureTime frame
Tracheal intubation response;The ED50 of propofol or ciprofol for suppressing tracheal intubation response;

Secondary

MeasureTime frame
Heart rate;Time to Loss of consciousness after administration of propofol or ciprofol;Injection pain;Adverse reactions;Bispectral index;Mean arterial pressure;Diastolic blood pressure;Systolic blood pressure;

Countries

China

Contacts

Public ContactXuesheng Liu/Hu Liu/Chen Chen

The First Affiliated Hospital of Anhui Medical University

ayliuhu@qq.com+86 186 5519 3385

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026